share_log
Moomoo 24/7 ·  Apr 9 09:19
Cadrenal Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for Tecarfarin for the Prevention of Thromboembolism and Thrombosis in Patients With an Implanted Mechanical Circulatory Support Device
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment